Thanks for the lesson. So Cimzia and Simponi have essentially the same labels as Humira?
I believe you - but I don't get it. If Cimzia and Simponi came on the scene many years later it would seem that they would at least have had to pass a non-inferiority trial against Humira, similar to Dew's comments regarding Incyte's 050.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.